Sanford Health Opens Crohn's Trials in Sioux Falls

Gastroenterologists are offering clinical trials for Crohn's disease for the first time in South Dakota.

Updated on Oct. 30, 2026 in Cancer

Isometric editorial illustration of a modern medical facility building, highlighting the expansion of specialized health services in Sioux Falls. — Sanford Health has launched South Dakota’s first clinical trials for Crohn’s disease, allowing local patients access to new treatments in Sioux Falls. AI Illustration. Upload story photo >

Live Poll

Would you prefer to participate in local clinical trials for chronic conditions if available?

Sanford Health has launched new clinical trials for patients suffering from Crohn's disease in Sioux Falls. This initiative marks the first time such research opportunities have been available to residents within South Dakota.

Why it matters

The introduction of these trials provides local patients access to potential new medical treatments without the need to travel long distances. This expansion increases the availability of specialized care for those managing the condition.

These clinical trials now allow patients to receive monitoring by local gastroenterologists. Eligible participants include those who have managed the illness for at least eight years.

The players

Sanford Health

This is a large, integrated health system that provides specialized medical care and research services across several states in the Upper Midwest.

The details

Gastroenterologists at Sanford Health are overseeing the program, providing medical monitoring for participants throughout the trial duration. Patients previously had to travel outside of the state to enroll in similar research studies for the condition.

The clinical trials were announced on October 30, 2026.

The Big Picture

This initiative follows a pattern set by the Crohn's & Colitis Foundation clinical research network to improve regional patient outcomes. The program expands research access in line with standards seen in established national clinical trial infrastructures.

Patients in the area can now pursue trial participation without the logistical burden of long-distance travel. This access may offer new treatment options for those who have lived with the condition for several years.

The takeaway

Patients interested in trial enrollment should consult with their gastroenterologist to determine if they meet specific health criteria. Expanding local research options can significantly improve the quality of care for those managing complex gastrointestinal conditions.